Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
-
+
FP09 - Novel Therapeutics and Targeted Therapies
- Type: Posters (Featured)
- Track: Novel Therapeutics and Targeted Therapies
- Presentations: 4
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
FP09.01 - Mobocertinib in Platinum-Pretreated EGFR Exon 20 Insertion+ Metastatic NSCLC Patients With/Without Prior Anti-PD(L)-1 Therapy
00:00 - 00:00 | Presenter: Pasi A. Janne
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P45 - Novel Therapeutics and Targeted Therapies - ALK/ROS1/MET
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
- Presentations: 18
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P45.03 - Tepotinib in Patients with MET exon 14 (METex14) Skipping NSCLC as Identified by Liquid (LBx) or Tissue (TBx) biopsy
00:00 - 00:00 | Presenter: Enriqueta Felip
- Abstract
Loading...
-
+
OA01 - The Impact of COVID-19 on Patients with Lung Cancer
- Type: Oral
- Track: Management of Lung Cancer in the Era of COVID-19
- Presentations: 5
- Moderators:Enriqueta Felip
- Coordinates: 9/08/2021, 08:15 - 09:15, Program Auditorium
-
+
OA01.01 - Analysis of Lung Cancer Patients Receiving SARS-CoV-2 Vaccines Revealed a Minority Subset With Poor Antibody Responses Relative to Controls
08:15 - 08:25 | Presenter: Jorge E Gomez
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA01.02 - Impact of COVID-19 Outbreak on Lung Cancer Diagnosis and Continuum of Care: Data From an Italian Multicenter Study
08:25 - 08:35 | Presenter: Luca Cantini
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA01.03 - Immune Checkpoint Inhibitor Dose Adaptation During the COVID-19 Pandemic in Non-Small Cell Lung Cancer– a Single-Center Experience
08:35 - 08:45 | Presenter: Lucie Brigitte Marie Hijmering-Kappelle
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA01.04 - Discussant
08:45 - 08:55 | Presenter: Suresh Ramalingam
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA01.05 - Live Discussion with Speakers
08:55 - 09:05
- Abstract
No abstract available for this presentation
-
+
MA04 - Current Status and Future Prospects of Pleural Mesothelioma and Thymoma
- Type: Mini Oral
- Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
- Presentations: 8
- Coordinates: 9/08/2021, 10:45 - 11:45, Program Auditorium
-
+
MA04.07 - Clinical Characteristics and Outcomes in Patients With Malignant Pleural Mesothelioma (MPM) with COVID-19 Infection
11:25 - 11:30 | Presenter: Susana Cedres
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
PL02 - Plenary 2: Presidential Symposium (Japanese, Mandarin, Spanish Translation Available)
- Type: Plenary
- Track: N.A.
- Presentations: 11
- Moderators:David Harpole
- Coordinates: 9/09/2021, 06:30 - 08:00, Program Auditorium
-
+
PL02.05 - IMpower010: Characterization of Stage IB-IIIA NSCLC Patients by Type and Extent of Therapy Prior to Adjuvant Atezolizumab
07:04 - 07:14 | Presenter: Nasser Altorki
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA09 - Expanding Immunotherapy Options for Non-Small Cell Lung Cancers
- Type: Oral
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 5
- Moderators:Rina Hui
- Coordinates: 9/09/2021, 09:30 - 10:30, Program Auditorium
-
+
OA09.01 - First-line Nivolumab + Ipilimumab + Chemo in Patients With Advanced NSCLC and Brain Metastases: Results From CheckMate 9LA
09:30 - 09:40 | Presenter: David Carbone
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA09.02 - Atezo-Brain: Single Arm Phase II Study of Atezolizumab Plus Chemotherapy in Stage IV NSCLC With Untreated Brain Metastases
09:40 - 09:50 | Presenter: Ernest Nadal
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
PL02A - Plenary 2: Presidential Symposium (Rebroadcast) (Japanese, Mandarin, Spanish Translation Available)
- Type: Plenary
- Track: N.A.
- Presentations: 11
- Moderators:David Harpole
- Coordinates: 9/09/2021, 14:30 - 16:00, Program Auditorium
-
+
PL02A.05 - IMpower010: Characterization of Stage IB-IIIA NSCLC Patients by Type and Extent of Therapy Prior to Adjuvant Atezolizumab
15:04 - 15:14 | Presenter: Nasser Altorki
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA14 - Pathologic Patterns, Genomic Alterations and Targeted Therapies in NSCLC
- Type: Mini Oral
- Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
- Presentations: 8
- Coordinates: 9/13/2021, 18:45 - 19:45, Program Auditorium
-
+
MA14.02 - RET Fusion Testing in Advanced Non-Small Cell Lung Carcinoma Patients: the RETING Study
18:50 - 18:55 | Author(s): Esther Conde
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.